The Medicare Prescription Drug Inflation Rebate Program will lower coinsurance for Medicare Part B beneficiaries for certain drugs, with savings between $2 and $390 per average dose starting April 1.

The annual list, now in its 17th year, was designed to celebrate companies that make ethical business practices a high priority. 

When human counselors are unavailable to provide work-based wellness coaching, robots can substitute—as long as the workers are comfortable with emerging technologies and the machines aren’t overly humanlike.

Along with expanding research into large-language models to rival OpenAI’s ChatGPC, the search-engine king is working on AI for improving maternal care, ultrasound access and tuberculosis screening.

Provention Bio's TZIELD is the first and only therapy to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and pediatric patients aged 8 years and older with Stage 2 T1D. 

According to the complaint, Rite Aid allegedly filled “at least” hundreds of thousands of unlawful prescriptions for controlled substances that lacked legitimate medical purpose, were not for a medically accepted indication or were not issued in the usual course of professional practice.

A new Alzheimer’s disease drug, Leqembi (lecanemab), will be covered by the Veterans Affairs for some patients, making the VA the first insurer to cover the drug.

Wary consumers can be convinced to allow AI into their healthcare habits by communications campaigns tuned to the ancient rhetorical categories of ethos, pathos and logos.